导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -0.48% | 47/71 |
| 近一周 | -3.27% | 38/80 |
| 近一月 | -5.44% | 45/80 |
| 近一季 | -12.49% | 51/80 |
| 近半年 | 2.83% | 46/73 |
| 近一年 | 0.32% | 48/69 |
| 近两年 | 23.61% | 54/66 |
| 近三年 | 46.62% | 35/58 |
| 成立以来 | 30.40% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.93% 46/76 |
19.08% 41/85 |
- - |
- - |
| 2025 | 13.64% 65/76 |
-3.01% 43/74 |
8.05% 53/74 |
9.34% 63/74 |
-0.83% 44/76 |
| 2024 | 27.38% 13/75 |
10.30% 13/67 |
7.62% 17/72 |
1.86% 50/74 |
5.35% 21/75 |
| 2023 | 7.94% 23/72 |
-0.93% 39/57 |
5.76% 29/64 |
-2.20% 17/68 |
5.33% 39/72 |
| 2022 | -28.32% 32/46 |
-12.61% 24/43 |
-13.29% 33/45 |
-5.40% 20/45 |
- 31/46 |
| 2021 | -14.62% 34/43 |
-10.27% 300/312 |
-0.56% 250/328 |
-8.71% 212/358 |
4.82% 6/43 |
| 2020 | 30.66% 17/41 |
-14.26% 184/280 |
27.93% 60/295 |
6.97% 75/299 |
11.36% 104/305 |
| 2019 | 18.17% 23/35 |
8.81% 146/258 |
-1.21% 202/268 |
0.92% 114/253 |
8.93% 87/266 |
| 2018 | -13.52% 10/31 |
- - |
- - |
- - |
-15.85% 178/241 |
| 2017 | 36.54% 7/30 |
- - |
- - |
- - |
- - |
| 2016 | -1.41% 19/31 |
- - |
- - |
- - |
- - |
| 2015 | -4.41% 13/30 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 2011 | - - |
- - |
- - |
- - |
- - |
| 2010 | - - |
- - |
- - |
- - |
- - |
| 2009 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 诺安油气能源 | 1.4840 | 19.20% |
| 平安港股医疗优选股票(QDII)A | 0.9420 | 17.84% |
| 平安港股医疗优选股票(QDII)C | 0.9385 | 17.67% |
| 创金合信全球医药生物股票发起(QDII)C | 1.5054 | 9.47% |
| 创金合信全球医药生物股票发起(QDII)A | 1.5257 | 7.60% |
| 宏利印度股票(QDII) | 1.3125 | 3.49% |
| 宏利印度股票(QDII)C | 1.3092 | 3.41% |
| 长城港股价值优选股票(QDII)C | 0.9674 | 1.82% |
| 华宝海外科技股票(QDII-LOF)A | 2.3545 | 1.69% |
| 华宝海外科技股票(QDII-LOF)C | 2.3331 | 1.62% |
| 华夏全球股票(QDII)(人民币) VS. 华宝海外科技股票(QDII(501312) |